Te Matau a Māui | Laboratory Services - User contributions [en]

File:I-STAT Patient Testing - Quick Guide.pdf

2026-06-28T23:32:28Z

Rwarwick: Rwarwick uploaded a new version of File:I-STAT Patient Testing - Quick Guide.pdf

File:I-STAT Troubleshooting.pdf

2026-06-28T23:30:43Z

Rwarwick: Rwarwick uploaded a new version of File:I-STAT Troubleshooting.pdf

File:I-STAT Overview.pdf

2026-06-28T23:25:04Z

Rwarwick: Rwarwick uploaded a new version of File:I-STAT Overview.pdf

File:Clinitek Urinalysis Quality Control.pdf

2025-12-15T23:12:43Z

Rwarwick: Rwarwick uploaded a new version of File:Clinitek Urinalysis Quality Control.pdf

Tests:Coaguchek

2025-12-10T23:00:38Z

Rwarwick:

{{DISPLAYTITLE: Coaguchek Pro II INR}}
[[Category:Tests]]
[[Category:POCT]]
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of Care, Coaguchek, INR
|-
|'''Specimen'''
|Finger-prick capillary blood
|-
|'''Minimum Volumes'''
|8uL
|-
|'''Test Availability'''
|24/7 Hastings
0730-1500 Wairoa
|-
|'''Where analysed'''
|Hastings Theatre, Wairoa Laboratory
|-
|'''Department'''
|Point of Care ext. 2453
|-
|'''Registration Code'''
|NPPT
|-
|'''Deletion Code'''
|1746
|}

[https://hawkesbaylabmanual.co.nz/wiki/images/c/c4/Coaguchek_Pro_II_Overview.pdf Coaguchek Pro II Overview]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e4/Coaguchek_Pro_II_Patient_Testing.pdf Coaguchek Pro II Patient Testing]

[https://hawkesbaylabmanual.co.nz/wiki/images/4/49/Coaguchek_Pro_II_Quality_Control.pdf Coaguchek Pro II Quality Control]

[https://hawkesbaylabmanual.co.nz/wiki/images/a/a3/Coaguchek_Pro_II_Troubleshooting.pdf Coaguchek Pro II Troubleshooting]

[https://hawkesbaylabmanual.co.nz/wiki/images/8/89/Coaguchek_Pro_II_Maintenance.pdf Coaguchek Pro II Maintenance]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e0/CoaguChek_Competency.pdf Coaguchek Competency Assessment]

Tests:Coaguchek

2025-12-10T23:00:20Z

Rwarwick:

{{DISPLAYTITLE: Coaguchek Pro II INR}}
[[Category:Tests]]
[[Category:POCT]]
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of Care, Coaguchek, INR
|-
|'''Specimen'''
|Finger-prick capillary blood
|-
|'''Minimum Volumes'''
|8uL
|-
|'''Test Availability'''
|24/7 Hastings
0730-1500 Wairoa
|-
|'''Where analysed'''
|Hastings Theatre, Wairoa Laboratory
|-
|'''Department'''
|Point of Care ext. 2453
|-
|'''Registration Code'''
|NPPT
|-
|'''Deletion Code'''
|1746
|}

[https://hawkesbaylabmanual.co.nz/wiki/images/c/c4/Coaguchek_Pro_II_Overview.pdf Coaguchek Pro II Overview][https://hawkesbaylabmanual.co.nz/wiki/images/e/e4/Coaguchek_Pro_II_Patient_Testing.pdf Coaguchek Pro II Patient Testing]

[https://hawkesbaylabmanual.co.nz/wiki/images/4/49/Coaguchek_Pro_II_Quality_Control.pdf Coaguchek Pro II Quality Control]

[https://hawkesbaylabmanual.co.nz/wiki/images/a/a3/Coaguchek_Pro_II_Troubleshooting.pdf Coaguchek Pro II Troubleshooting]

[https://hawkesbaylabmanual.co.nz/wiki/images/8/89/Coaguchek_Pro_II_Maintenance.pdf Coaguchek Pro II Maintenance]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e0/CoaguChek_Competency.pdf Coaguchek Competency Assessment]

File:Coaguchek Pro II Maintenance.pdf

2025-12-10T21:17:30Z

Rwarwick:

File:Coaguchek Pro II Troubleshooting.pdf

2025-12-10T21:13:44Z

Rwarwick:

File:Coaguchek Pro II Quality Control.pdf

2025-12-10T21:10:40Z

Rwarwick:

File:Coaguchek Pro II Patient Testing.pdf

2025-12-10T21:07:39Z

Rwarwick:

File:Coaguchek Pro II Overview.pdf

2025-12-10T21:05:19Z

Rwarwick:

Tests:Coaguchek

2025-12-10T21:04:01Z

Rwarwick:

Tests:Coaguchek

2025-12-10T21:03:23Z

Rwarwick:

File:Hba1c Patient testing.pdf

2025-11-05T01:02:40Z

Rwarwick: Rwarwick uploaded a new version of File:Hba1c Patient testing.pdf

File:I-STAT Overview.pdf

2025-11-04T22:23:38Z

Rwarwick: Rwarwick uploaded a new version of File:I-STAT Overview.pdf

File:TEG Patient testing.pdf

2025-10-29T21:01:15Z

Rwarwick: Rwarwick uploaded a new version of File:TEG Patient testing.pdf

File:Hemocue Quality Control.pdf

2025-10-29T20:59:22Z

Rwarwick: Rwarwick uploaded a new version of File:Hemocue Quality Control.pdf

Point of Care Department Information

2025-10-08T01:07:33Z

Rwarwick: Removed PCR testing from Wairoa

== '''Definition: ''' ==
Point of Care Testing (POCT) is the performance by non-laboratory staff of an analytical test outside the conventional laboratory, at the site of or in the vicinity of the patient.

== '''Devices: ''' ==
Devices for POCT testing range from basic dipsticks, to simple hand held devices such as glucose meters, through to complex analysers more commonly seen in a conventional laboratory, like blood gas analysers.

== '''POCT Governance: ''' ==
Laboratory Advisory Group also referred to as the POCT Committee.

== '''Benefits:''' ==
The use of Point of Care Testing may have a number of benefits for clinicians and patients. Thus POCT can be an important addition to laboratory-based analysis.

Benefits may include:

* improved turnaround time by shortening pre-analytical, analytical and post-analytical steps
* reduced therapeutic turnaround time
* improved monitoring of certain conditions where frequent testing is desirable such as diabetes and oral anticoagulant monitoring
* improved convenience and access to service e.g. for elderly patients
* smaller sample volumes which may be less invasive
* availability of rapid results to facilitate patient management
* opportunistic screening of the public for early identification of certain conditions
* ability to provide laboratory tests in remote locations or outside laboratory hours
* economic benefits may also be realised because although POCT testing is generally more expensive than conventional laboratory testing, POCT may offer economic benefits in terms of reduced clinic visits, length of hospital stay and hospital admissions

However, it should be noted that faster availability of results is only an advantage if the availability of results is the rate-limiting step in clinical care.

== '''Risks:''' ==
There are risks involved in the use of POCT devices, and therefore this testing should be limited to those circumstances where they are the only or the best solution to obtain test results when compared with testing in the central laboratory. Risks may include:

* POCT introduction without adequate investigation of clinical need
* inaccurate results due to lack of training or expertise, insufficient quality testing, or failure to recognise erroneous results, which may cause patient harm
* problems of comparability of results between different methods (laboratory versus POCT)
* increased costs due to additional instrumentation, expensive reagents, enrolment in external quality assurance programmes
* inadequate documentation of results and reporting
* increased workload for clinical staff
* the availability of arrays of screening tests which may result in inappropriate testing
* risks to patients as a result of implementation of non-performing devices or failure to recognise the limitations of POCT devices

To overcome the disadvantages requires significant resources and so careful consideration should be given to the clinical need before contemplating this type of testing. The advantages of POCT only hold true if the test result provided is accurate and reliable, and improves patient outcomes.

== '''Assessment of Clinical Need: ''' ==
In many cases improving the patient pathway and experience will be major considerations when introducing POCT. To be effective, POCT must deliver an equivalent level of quality and be at least as clinically effective as the alternative, and applied within the correct setting. These questions will help in assessing the clinical need for POCT:

* Does the current method of providing the service adequately meet the clinical need, and if it does not, what is the problem and can it be rectified?

* Is access to the laboratory a problem for patients, and can that be rectified?
* Which groups of patients need testing and what test(s) need to be performed?
* Will POCT enable more rapid or effective diagnosis, treatment or management?
* Will POCT provide a cost-effective alternative to laboratory testing?
* How would a POCT service compare to the current service in terms of quality?
* Would any change in quality be appropriate for best management of the patient?
* Can you provide evidence that POCT will provide a measurable clinical benefit

== '''Selection Criteria:''' ==
All new POCT devices or systems must undergo a rigorous evaluation procedure prior to their introduction. This will include a laboratory evaluation and may also include an on-site clinical evaluation.

For a candidate POCT device to be accepted the following criteria must be established:

* The results produced must be required for a rapid (urgent) clinical decision within a timescale that the central laboratory cannot achieve.
* The performance of the device and the results produced must consistently be of acceptable quality, and compatible with laboratory test ranges.
* The resource implications must be acceptable.
* The risks must be identified and manageable.
* There should be a strong evidence base for the test in question.

== '''Information Technology: ''' ==
All results obtained from POCT testing must be recorded and become part of the patient health record. Information technology (IT) capability can aid in minimising some of the potential sources of error in POCT testing and promote compliance with operator and patient identification procedures, test procedures and quality control requirements. Wherever possible, IT capable devices must be the selection of choice, and include software that:

* requires operator identification
* requires patient identification
* checks quality control
* transfers results directly to the patient record

Other desirable features which should be considered include:

* bidirectional data communication to allow patient data to be uploaded to the device, and results matched with patient information to be fed back to the information system
* access and data should be secure to ensure patient confidentiality
* ability to scan barcodes to facilitate accurate information entry, - operator ID, patient ID and lot numbers for consumables
* allow easy and regular monitoring of QC information to continually evaluate system performance

== '''Applications for POCT: ''' ==
In the first instance, application for new or additional POCT should be made to the POCT Quality Manager using the application form in Appendix 1 of the DHB policy. Once the application is passed on and approved by the Laboratory Committee, the POCT Quality Manager is responsible for the evaluation and recommendation of appropriate equipment in consultation with the Product Evaluation Committee.

== '''Financial Implications: ''' ==
The clinical areas installing POCT testing/devices are responsible for the costs of:

* The device
* The consumables
* Quality control material (QC)
* Enrolment and participation in external quality assurance programmes (EQA)
* Maintenance, repair and replacement
* An appropriate share of any connectivity costs and ongoing licence fees

Laboratory staff will have oversight of these activities, and provide guidance regarding suitable alternatives which must comply with laboratory IANZ accreditation requirements.

== '''References''' ==
For detailed information on Point Of Care Testing requirements refer to:

HBDHB Point of Care Testing Policy HBDHB/CPG/101 (2020)

New Zealand Best Practice Guidelines for Point of Care Testing (2022)

The HBDHB POCT Manager (as appointed by the laboratory) is responsible for the implementation and maintenance of the POCT Quality Management System (QMS) for HBDHB clinical areas. The QMS is based ISO 5189:2022, in line with IANZ accreditation requirements and national and international best practice. Refer to HBDHB POCT Policy CPG/SPG101 and relevant POCT Manuals for further information regarding the POCT QMS.

== '''Point of Care Quality Manager Job Description''': ==

* Document, implement and maintain the POCT Quality Management System
* Be responsible for ensuring that all POCT is performed to an appropriate standard.
* Maintain a record of all POCT equipment within the HBDHB.
* Be responsible for ensuring that all POCT users have current competency training and documentation.
* Be responsible for ensuring regular quality assurance is maintained and quality control samples are analysed on POCT devices, with up to date documentation and history.
* Maintain (monitor) service records for each device.
* Be responsible for trouble shooting of POCT devices and overseeing the maintenance of up to date documentation and history.

Competency of users is undertaken annually and documented appropriately.

All methods manuals and associated POCT documents are also reviewed annually.

'''As a general rule all POCT equipment is owned, operated and funded by the clinical areas.'''

The exceptions to this are:

Wairoa I-STAT, poch-i100 and Lactate meter in the Acute Ward is owned by the Laboratory. There is no maintenance agreement for these instruments.

== '''Hastings''' ==
{| class="wikitable"
|'''Equipment'''
|'''Tests'''
|'''Location'''
|-
|Nova Glucose Meters
|Glucose, Ketone
|Inpatient Wards, Radiology
|-
|Xpress Glucose Meters
|Glucose
|Villa’s (OPD), District Nurses incl Napier
|-
|Hemocue, CoaguChek, TEG
|Hgb, INR, TEG
|Tech Room, Theatre
|-
|Nova Lactate Meter, Fetal Fibronectin
|Lactate, FFN
|Maternity
|-
|Cobas B101
|HbA1c
|Diabetes Centre
|-
|ABL90
|Blood Gas
|ICU
|-
|Siemens Clinitek
|Urinalysis
|ED
|}

== '''Wairoa''' ==
{| class="wikitable"
|'''Equipment'''
|'''Test'''
|'''Location'''
|-
|Nova Glucose Meter
|Glucose, Ketones
|Acute Ward
|-
|Nova Lactate Meter
|Lactate
|Acute Ward, Laboratory
|-
|Nova Xpress Glucose Meter
|Glucose
|District Nurses
|-
|I-STAT
|UECG, Blood Gas, Trop I, INR
|Acute Ward, Laboratory
|-
|CoaguChek
|INR
|Laboratory
|-
|Pochi 100i
|FBC
|Acute Ward, Laboratory
|-
|Cobas B101
|C-reactive Protein
|Acute Ward
|}

== '''Central Hawke’s Bay Health Centre (CHB)''' ==
{| class="wikitable"
|'''Equipment'''
|'''Tests'''
|'''Location'''
|-
|Nova Glucose Meters
|Glucose, Ketones
|General Ward
|-
|I-STAT
|Trop I
|Laboratory
|}

== '''Quality Control''' ==
{| class="wikitable"
|'''EQA Programme'''
|'''Test'''
|'''Frequency'''
|-
|RCPA –ICU ABL90
|Blood Gas
|Monthly
|-
|RCPA -Wairoa
|Blood Gas, Chem 8+, Troponin I
|Monthly
|-
|RCPA – Wairoa/Hastings
|INR
|Bi-Monthly
|-
|RCPA - Wairoa
|Ketones
|Bi-Monthly
|-
|RCPA - Wairoa
|CRP
|Monthly
|-
|Waikato EQA - ED
|Urinalysis
|Monthly
|-
|Waikato EQA – Wairoa/Hastings/CHB
|Glucose
|Monthly
|-
|HB Labs Sample Swap - Wairoa
|FBC
|Weekly
|-
|Sample Comparison (b101 vs D100 Hastings)
|HbA1c
|Monthly
|-
|Sample Comparison (meter vs ABL Hastings)
|Lactate
|Monthly
|-
|Sample Comparison (Hemocue vs XN-3000)
|Haemoglobin
|Monthly
|-
|Sample Comparison (ABL800 Lab vs ABL90 ICU)
|Blood Gas
|Weekly
|-
|Sample Comparison (Alinity vs B101)
|CRP
|Monthly
|-
|Sample Comparison (Alinity vs iSTAT)
|Chem8
|Monthly
|-
|RCPA sample comparison - CHB
|Troponin I
|Bi-Monthly
|}

{| class="wikitable"
|'''Internal QC'''
|'''Frequency'''
|'''Performed by'''
|-
|ABL90
|3x Daily
|Analyser - automated
|-
|FBC
|Daily
|Wairoa Laboratory Staff
|-
|Nova Glucose & Ketone
|Daily
|Ward Staff
|-
|Nova Xpress Glucose
|Weekly
|District Nurses or HCA’s
|-
|I-STAT – electronic checks
|Daily (NOT required for Alinity)
|Wairoa/CHB
|-
|I-STAT – liquid QC
|Monthly or New lot number/Delivery
|Wairoa/CHB
|-
|Coaguchek
|Monthly or New lot number/Delivery
|Wairoa Laboratory Staff/ Anaesthetic Technician
|-
|Cobas b101
|Monthly or New lot number/Delivery
|Diabetes Clinic Staff Nurse
|-
|Hemocue
|Monthly or New lot number/Delivery
|Anaesthetic Technician
|-
|Lactate
|Weekly
|Wairoa/Maternity Staff
|-
|TEG
|Fortnightly
|Anaesthetic Technicians
|-
|CRP
|Weekly
|Wairoa Laboratory Staff
|}

All Internal and External QC is regularly reviewed and commented on by the POC QM and/or Chemical Pathologist and acted upon if required.

== '''Out of Hours Support''': ==
Wairoa For problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.

Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.

Lactate No out of hours support, send sample to the laboratory.

Hemocue No out of hours support, send sample to the laboratory.

ABL90 ICU No out of hours support, send sample to the laboratory.

Fetal Fibronection No out of hours support.

TEG No out of hours support.

CHB Not used out of hours.

B101 No out of hours support.

Urinalysis No out of hours support.

== '''Equipment Inventory:''' ==
All POC devices and instruments are documented and recorded on a spreadsheet located at:

J:\Departments\Equipment Inventory\MASTER Equipment Inventory

Under the POC tab. This contains information relating to age of device, model, asset number and also hyperlinks to the individual devices Equipment Log. This log documents issues and troubleshooting.

File:Nova Meter Lactate.pdf

2025-10-05T21:53:18Z

Rwarwick: Rwarwick uploaded a new version of File:Nova Meter Lactate.pdf

File:Hba1c QC.pdf

2025-10-01T23:17:49Z

Rwarwick: Rwarwick uploaded a new version of File:Hba1c QC.pdf

File:Nova Meters - Glucose-Ketone.pdf

2025-08-27T21:56:23Z

Rwarwick: Rwarwick uploaded a new version of File:Nova Meters - Glucose-Ketone.pdf

File:ABL90 POCT Blood Gas Analyser Troubleshooting.pdf

2025-04-14T21:25:53Z

Rwarwick: Rwarwick uploaded a new version of File:ABL90 POCT Blood Gas Analyser Troubleshooting.pdf

Point of Care Department Information

2025-02-26T21:07:01Z

Rwarwick: /* Hastings */

== '''Definition: ''' ==
Point of Care Testing (POCT) is the performance by non-laboratory staff of an analytical test outside the conventional laboratory, at the site of or in the vicinity of the patient.

== '''Devices: ''' ==
Devices for POCT testing range from basic dipsticks, to simple hand held devices such as glucose meters, through to complex analysers more commonly seen in a conventional laboratory, like blood gas analysers.

== '''POCT Governance: ''' ==
Laboratory Advisory Group also referred to as the POCT Committee.

== '''Benefits:''' ==
The use of Point of Care Testing may have a number of benefits for clinicians and patients. Thus POCT can be an important addition to laboratory-based analysis.

Benefits may include:

* improved turnaround time by shortening pre-analytical, analytical and post-analytical steps
* reduced therapeutic turnaround time
* improved monitoring of certain conditions where frequent testing is desirable such as diabetes and oral anticoagulant monitoring
* improved convenience and access to service e.g. for elderly patients
* smaller sample volumes which may be less invasive
* availability of rapid results to facilitate patient management
* opportunistic screening of the public for early identification of certain conditions
* ability to provide laboratory tests in remote locations or outside laboratory hours
* economic benefits may also be realised because although POCT testing is generally more expensive than conventional laboratory testing, POCT may offer economic benefits in terms of reduced clinic visits, length of hospital stay and hospital admissions

However, it should be noted that faster availability of results is only an advantage if the availability of results is the rate-limiting step in clinical care.

== '''Risks:''' ==
There are risks involved in the use of POCT devices, and therefore this testing should be limited to those circumstances where they are the only or the best solution to obtain test results when compared with testing in the central laboratory. Risks may include:

* POCT introduction without adequate investigation of clinical need
* inaccurate results due to lack of training or expertise, insufficient quality testing, or failure to recognise erroneous results, which may cause patient harm
* problems of comparability of results between different methods (laboratory versus POCT)
* increased costs due to additional instrumentation, expensive reagents, enrolment in external quality assurance programmes
* inadequate documentation of results and reporting
* increased workload for clinical staff
* the availability of arrays of screening tests which may result in inappropriate testing
* risks to patients as a result of implementation of non-performing devices or failure to recognise the limitations of POCT devices

To overcome the disadvantages requires significant resources and so careful consideration should be given to the clinical need before contemplating this type of testing. The advantages of POCT only hold true if the test result provided is accurate and reliable, and improves patient outcomes.

== '''Assessment of Clinical Need: ''' ==
In many cases improving the patient pathway and experience will be major considerations when introducing POCT. To be effective, POCT must deliver an equivalent level of quality and be at least as clinically effective as the alternative, and applied within the correct setting. These questions will help in assessing the clinical need for POCT:

* Does the current method of providing the service adequately meet the clinical need, and if it does not, what is the problem and can it be rectified?

* Is access to the laboratory a problem for patients, and can that be rectified?
* Which groups of patients need testing and what test(s) need to be performed?
* Will POCT enable more rapid or effective diagnosis, treatment or management?
* Will POCT provide a cost-effective alternative to laboratory testing?
* How would a POCT service compare to the current service in terms of quality?
* Would any change in quality be appropriate for best management of the patient?
* Can you provide evidence that POCT will provide a measurable clinical benefit

== '''Selection Criteria:''' ==
All new POCT devices or systems must undergo a rigorous evaluation procedure prior to their introduction. This will include a laboratory evaluation and may also include an on-site clinical evaluation.

For a candidate POCT device to be accepted the following criteria must be established:

* The results produced must be required for a rapid (urgent) clinical decision within a timescale that the central laboratory cannot achieve.
* The performance of the device and the results produced must consistently be of acceptable quality, and compatible with laboratory test ranges.
* The resource implications must be acceptable.
* The risks must be identified and manageable.
* There should be a strong evidence base for the test in question.

== '''Information Technology: ''' ==
All results obtained from POCT testing must be recorded and become part of the patient health record. Information technology (IT) capability can aid in minimising some of the potential sources of error in POCT testing and promote compliance with operator and patient identification procedures, test procedures and quality control requirements. Wherever possible, IT capable devices must be the selection of choice, and include software that:

* requires operator identification
* requires patient identification
* checks quality control
* transfers results directly to the patient record

Other desirable features which should be considered include:

* bidirectional data communication to allow patient data to be uploaded to the device, and results matched with patient information to be fed back to the information system
* access and data should be secure to ensure patient confidentiality
* ability to scan barcodes to facilitate accurate information entry, - operator ID, patient ID and lot numbers for consumables
* allow easy and regular monitoring of QC information to continually evaluate system performance

== '''Applications for POCT: ''' ==
In the first instance, application for new or additional POCT should be made to the POCT Quality Manager using the application form in Appendix 1 of the DHB policy. Once the application is passed on and approved by the Laboratory Committee, the POCT Quality Manager is responsible for the evaluation and recommendation of appropriate equipment in consultation with the Product Evaluation Committee.

== '''Financial Implications: ''' ==
The clinical areas installing POCT testing/devices are responsible for the costs of:

* The device
* The consumables
* Quality control material (QC)
* Enrolment and participation in external quality assurance programmes (EQA)
* Maintenance, repair and replacement
* An appropriate share of any connectivity costs and ongoing licence fees

Laboratory staff will have oversight of these activities, and provide guidance regarding suitable alternatives which must comply with laboratory IANZ accreditation requirements.

== '''References''' ==
For detailed information on Point Of Care Testing requirements refer to:

HBDHB Point of Care Testing Policy HBDHB/CPG/101 (2020)

New Zealand Best Practice Guidelines for Point of Care Testing (2022)

The HBDHB POCT Manager (as appointed by the laboratory) is responsible for the implementation and maintenance of the POCT Quality Management System (QMS) for HBDHB clinical areas. The QMS is based ISO 5189:2022, in line with IANZ accreditation requirements and national and international best practice. Refer to HBDHB POCT Policy CPG/SPG101 and relevant POCT Manuals for further information regarding the POCT QMS.

== '''Point of Care Quality Manager Job Description''': ==

* Document, implement and maintain the POCT Quality Management System
* Be responsible for ensuring that all POCT is performed to an appropriate standard.
* Maintain a record of all POCT equipment within the HBDHB.
* Be responsible for ensuring that all POCT users have current competency training and documentation.
* Be responsible for ensuring regular quality assurance is maintained and quality control samples are analysed on POCT devices, with up to date documentation and history.
* Maintain (monitor) service records for each device.
* Be responsible for trouble shooting of POCT devices and overseeing the maintenance of up to date documentation and history.

Competency of users is undertaken annually and documented appropriately.

All methods manuals and associated POCT documents are also reviewed annually.

'''As a general rule all POCT equipment is owned, operated and funded by the clinical areas.'''

The exceptions to this are:

Wairoa I-STAT, poch-i100 and Lactate meter in the Acute Ward is owned by the Laboratory. There is no maintenance agreement for these instruments.

== '''Hastings''' ==
{| class="wikitable"
|'''Equipment'''
|'''Tests'''
|'''Location'''
|-
|Nova Glucose Meters
|Glucose, Ketone
|Inpatient Wards, Radiology
|-
|Xpress Glucose Meters
|Glucose
|Villa’s (OPD), District Nurses incl Napier
|-
|Hemocue, CoaguChek, TEG
|Hgb, INR, TEG
|Tech Room, Theatre
|-
|Nova Lactate Meter, Fetal Fibronectin
|Lactate, FFN
|Maternity
|-
|Cobas B101
|HbA1c
|Diabetes Centre
|-
|ABL90
|Blood Gas
|ICU
|-
|Siemens Clinitek
|Urinalysis
|ED
|}

== '''Wairoa''' ==
{| class="wikitable"
|'''Equipment'''
|'''Test'''
|'''Location'''
|-
|Nova Glucose Meter
|Glucose, Ketones
|Acute Ward
|-
|Nova Lactate Meter
|Lactate
|Acute Ward, Laboratory
|-
|Nova Xpress Glucose Meter
|Glucose
|District Nurses
|-
|I-STAT
|UECG, Blood Gas, Trop I, INR
|Acute Ward, Laboratory
|-
|CoaguChek
|INR
|Laboratory
|-
|Pochi 100i
|FBC
|Acute Ward, Laboratory
|-
|Pluslife PCR
|Covid-19, Influenza A&B, RSV
|Acute Ward
|-
|Cobas B101
|C-reactive Protein
|Acute Ward
|}

== '''Central Hawke’s Bay Health Centre (CHB)''' ==
{| class="wikitable"
|'''Equipment'''
|'''Tests'''
|'''Location'''
|-
|Nova Glucose Meters
|Glucose, Ketones
|General Ward
|-
|I-STAT
|Trop I
|Laboratory
|}

== '''Quality Control''' ==
{| class="wikitable"
|'''EQA Programme'''
|'''Test'''
|'''Frequency'''
|-
|RCPA –ICU ABL90
|Blood Gas
|Monthly
|-
|RCPA -Wairoa
|Blood Gas, Chem 8+, Troponin I
|Monthly
|-
|RCPA – Wairoa/Hastings
|INR
|Bi-Monthly
|-
|RCPA - Wairoa
|Ketones
|Bi-Monthly
|-
|RCPA - Wairoa
|CRP
|Monthly
|-
|Waikato EQA - ED
|Urinalysis
|Monthly
|-
|Waikato EQA – Wairoa/Hastings/CHB
|Glucose
|Monthly
|-
|HB Labs Sample Swap - Wairoa
|FBC
|Weekly
|-
|Sample Comparison (b101 vs D100 Hastings)
|HbA1c
|Monthly
|-
|Sample Comparison (meter vs ABL Hastings)
|Lactate
|Monthly
|-
|Sample Comparison (Hemocue vs XN-3000)
|Haemoglobin
|Monthly
|-
|Sample Comparison (ABL800 Lab vs ABL90 ICU)
|Blood Gas
|Weekly
|-
|Sample Comparison (Alinity vs B101)
|CRP
|Monthly
|-
|Sample Comparison (Alinity vs iSTAT)
|Chem8
|Monthly
|-
|RCPA sample comparison - CHB
|Troponin I
|Bi-Monthly
|}

{| class="wikitable"
|'''Internal QC'''
|'''Frequency'''
|'''Performed by'''
|-
|ABL90
|3x Daily
|Analyser - automated
|-
|FBC
|Daily
|Wairoa Laboratory Staff
|-
|Nova Glucose & Ketone
|Daily
|Ward Staff
|-
|Nova Xpress Glucose
|Weekly
|District Nurses or HCA’s
|-
|I-STAT – electronic checks
|Daily (NOT required for Alinity)
|Wairoa/CHB
|-
|I-STAT – liquid QC
|Monthly or New lot number/Delivery
|Wairoa/CHB
|-
|Coaguchek
|Monthly or New lot number/Delivery
|Wairoa Laboratory Staff/ Anaesthetic Technician
|-
|Cobas b101
|Monthly or New lot number/Delivery
|Diabetes Clinic Staff Nurse
|-
|Hemocue
|Monthly or New lot number/Delivery
|Anaesthetic Technician
|-
|Lactate
|Weekly
|Wairoa/Maternity Staff
|-
|TEG
|Fortnightly
|Anaesthetic Technicians
|-
|CRP
|Weekly
|Wairoa Laboratory Staff
|}

All Internal and External QC is regularly reviewed and commented on by the POC QM and/or Chemical Pathologist and acted upon if required.

== '''Out of Hours Support''': ==
Wairoa For problems with POCT equipment on the ward after hours, consult with Associate Clinical Nurse Manager. If further support is required contact Wairoa Laboratory staff or POC QM.

Glucose /Ketones For problems with glucose meters out of hours contact the laboratory for a loan meter.

Lactate No out of hours support, send sample to the laboratory.

Hemocue No out of hours support, send sample to the laboratory.

ABL90 ICU No out of hours support, send sample to the laboratory.

Fetal Fibronection No out of hours support.

TEG No out of hours support.

CHB Not used out of hours.

B101 No out of hours support.

Urinalysis No out of hours support.

== '''Equipment Inventory:''' ==
All POC devices and instruments are documented and recorded on a spreadsheet located at:

J:\Departments\Equipment Inventory\MASTER Equipment Inventory

Under the POC tab. This contains information relating to age of device, model, asset number and also hyperlinks to the individual devices Equipment Log. This log documents issues and troubleshooting.

Main Page

2025-02-17T01:57:57Z

Rwarwick: /* Key Contacts */

__NOTOC__
[[File:IANZLogo small.jpg|thumb|link=https://www.ianz.govt.nz/]]
Welcome to the Te Whatu Ora Te Matau a Māui Hawkes Bay Laboratory services Manual and test guide. Departmental information, guidance documents, and policies can be found in the sidebar on the left (desktop only).

The lab test guide can be searched in the search bar below, or at any time from the search bar at the top of the page. Alternatively a full list of available tests is available here: [[:Category:Tests|'''Full test list here (click)''']]

=== '''Search tests here:''' ===
Tests not listed here will be referred to our reference laboratory Canterbury Health Laboratories (CHL) - [https://www.chl.co.nz/test-manager/ Click here]
{| class="wikitable"
!<inputbox>
type=create
break=no
type=search
type=fulltext
width = 30
placeholder=Enter test name here
</inputbox>
|}

=== '''Search entire manual here:''' ===
{| class="wikitable"
|+
!<inputbox>
type=create
break=no
type=search
type=fulltext
width = 30
placeholder=Enter search term here
namespaces=Main**,File**,Tests**
</inputbox>
|}

===Opening Hours===
{| class="wikitable"
!
!
|-
|
====Hawkes Bay Hospital Laboratory====
Lab open hours 24/7

Phlebotomy hours at Villa 8

Mon – Fri 0800 – 1700

Ph 8781308 ext 2452
|
====Central Hawkes Bay Health Centre Laboratory====
Lab open hours Mon - Fri 0730-1700

Phlebotomy hours

Mon – Fri 0730 – 1600

Ph 06 8587797 ext 5553
|-
|

====Napier Health Centre Laboratory====
Lab open hours Mon – Fri 0800 – 1700

Phlebotomy hours
Mon – Fri 0800 – 1700

Ph 06 8341815 ext 4142
|
====Wairoa Hospital Laboratory====
Lab open hours Mon – Fri 0730 – 1630

Phlebotomy hours
Mon – Fri 0730 – 1500

Ph 06 8389710 ext 4859
|}

===Key Contacts===
{| class="wikitable"
|+
!Name
!Position
!Internal ext
!Ext Ph
|-
|Andrew Burns
|Clinical Director
|
|027 243 1754
|-
|Tim Aitken
|Laboratory Manager
|
|022 122 0645
|-
|Pam Russell
|Quality Manager
|2538
|
|-
|Grace Lim
|HOD Haematology
|6249
|
|-
|Mari-Sann van Aardt
|HOD Biochemistry
|2449
|
|-
|Lynne Morgan
|HOD Pre-Analytical
|2603
|
|-
|Tony Morgan
|HOD Transfusion Medicine (Blood bank)
|2629
|
|-
|Neil Campbell
|HOD Microbiology
|2630
|
|-
|Jade Chetty
|HOD Histology
|2485
|
|-
|Rebecca Warwick
|POCT Quality Manager
|2453
|027 246 6724
|}

=== '''Feedback''' ===
If you have a specimen specific enquiry, please [mailto:laboratory.office@hbdhb.govt.nz click here]. We will typically acknowledge and respond to your email within 2 working days.

If you would like to provide a service feedback or concern to the laboratory, please [mailto:feedback@hbdhb.govt.nz click here]. The Hawke's Bay Hospital Consumer Engagement Team will acknowledge your feedback within 20 working days.

[[File:Labnet Logo.jpg|none|thumb]]
[[File:CHL-Logo.png|none|thumb|link=https://www.chl.co.nz/test-manager/]]
Website by Chris Greenwood 2022

Reviewed by Tim Aitken Oct 2024

File:Clinitek Urinalysis Quality Control.pdf

2025-02-17T01:57:00Z

Rwarwick: Rwarwick uploaded a new version of File:Clinitek Urinalysis Quality Control.pdf

File:Nova Meter - Competency HCA.pdf

2025-01-23T23:21:52Z

Rwarwick: Rwarwick uploaded a new version of File:Nova Meter - Competency HCA.pdf

Tests:POCT CRP

2025-01-21T02:19:51Z

Rwarwick:

{{DISPLAYTITLE:CRP}}
[[Category:Tests]]
[[Category:POCT]]
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of care, CRP, C-reactive protein
|-
|'''Specimen'''
|Lithium Heparin (dark green) or fingerprick
|-
|'''Test Availability'''
|24/7
|-
|'''Turnaround Time'''
|4 minutes
|-
|'''Where analysed'''
|Wairoa ED
|-
|'''Department'''
|Point of Care
|-
|'''Registration Code'''
|CRPP
|-
|'''Deletion Code'''
|0078
|}
[https://hawkesbaylabmanual.co.nz/wiki/images/c/c9/POCT_CRP_Overview.pdf CRP Overview]

[https://hawkesbaylabmanual.co.nz/wiki/images/8/83/POCT_CRP_Patient_Testing.pdf CRP Patient testing]

Tests:POCT CRP

2025-01-21T02:19:08Z

Rwarwick:

Tests:POCT CRP

2025-01-21T02:17:26Z

Rwarwick:

Tests:POCT CRP

2025-01-21T02:17:03Z

Rwarwick:

{{DISPLAYTITLE: POCT CRP}}
[[Category:Tests]]
[[Category:POCT]]
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of care, CRP, C-reactive protein
|-
|'''Specimen'''
|Lithium Heparin (dark green) or fingerprick
|-
|'''Test Availability'''
|24/7
|-
|'''Turnaround Time'''
|4 minutes
|-
|'''Where analysed'''
|Wairoa ED
|-
|'''Department'''
|Point of Care
|-
|'''Registration Code'''
|CRPP
|-
|'''Deletion Code'''
|0078
|}

Tests:POCT CRP

2025-01-21T02:15:44Z

Rwarwick:

{{DISPLAYTITLE: POCT CRP}}
[[Category:Tests]]
[[Category:POCT]]

Tests:POCT CRP

2025-01-21T02:13:51Z

Rwarwick: Created page with "{| class="wikitable" |'''Synonym(s)''' |POCT, Point of care, CRP, C-reactive protein |- |'''Specimen''' |Lithium Heparin (Dark green) or fingerprick |- |'''Test Availability''' |24/7 |- |'''Turnaround Time''' |4 minutes |- |'''Where analysed''' |Wairoa ED |- |'''Department''' |Point of Care |- |'''Registration Code''' |CRPP |- |'''Deletion Code''' |0078 |}"

{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of care, CRP, C-reactive protein
|-
|'''Specimen'''
|Lithium Heparin (Dark green) or fingerprick
|-
|'''Test Availability'''
|24/7
|-
|'''Turnaround Time'''
|4 minutes
|-
|'''Where analysed'''
|Wairoa ED
|-
|'''Department'''
|Point of Care
|-
|'''Registration Code'''
|CRPP
|-
|'''Deletion Code'''
|0078
|}

File:POCT CRP Patient Testing.pdf

2025-01-21T02:07:31Z

Rwarwick:

File:POCT CRP Overview.pdf

2025-01-21T02:07:06Z

Rwarwick:

File:Nova Meter Lactate.pdf

2024-11-08T01:59:53Z

Rwarwick: Rwarwick uploaded a new version of File:Nova Meter Lactate.pdf

File:I-STAT Overview.pdf

2024-11-07T22:42:56Z

Rwarwick: Rwarwick uploaded a new version of File:I-STAT Overview.pdf

File:Pochi-100 quality control.pdf

2024-11-05T02:07:02Z

Rwarwick: Rwarwick uploaded a new version of File:Pochi-100 quality control.pdf

File:Nova Meters Quality Control.pdf

2024-10-30T03:23:36Z

Rwarwick: Rwarwick uploaded a new version of File:Nova Meters Quality Control.pdf

File:HCUE Troubleshooting.pdf

2024-10-03T00:58:30Z

Rwarwick: Rwarwick uploaded a new version of File:HCUE Troubleshooting.pdf

File:HCUE Maintenance.pdf

2024-10-03T00:52:12Z

Rwarwick: Rwarwick uploaded a new version of File:HCUE Maintenance.pdf

Tests:Hemocue

2024-10-03T00:41:35Z

Rwarwick:

{{DISPLAYTITLE: Hemocue}}
[[Category:Tests]]
[[Category:POCT]]
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of Care, Hemocue, Hb, Hemoglobin
|-
|'''Specimen'''
|Finger-prick capillary blood
|-
|'''Test Availability'''
|24/7
|-
|'''Where analysed'''
|Hastings Theatre
|-
|'''Department'''
|Point of Care ext. 2453
|}
[https://hawkesbaylabmanual.co.nz/wiki/images/3/3f/HCUE_Overview.pdf Hemocue Hb 201+ Overview]

[https://hawkesbaylabmanual.co.nz/wiki/images/a/ac/Hemocue_Patient_Testing.pdf Hemocue Patient Testing]

[https://hawkesbaylabmanual.co.nz/wiki/images/1/18/HCUE_Patient_testing_quick_guide.pdf Hemocue Patient Testing Quick Guide]

[https://hawkesbaylabmanual.co.nz/wiki/images/c/cd/Hemocue_Quality_Control.pdf Hemocue Quality Control]

[https://hawkesbaylabmanual.co.nz/wiki/images/f/f6/HCUE_Maintenance.pdf Hemocue Maintenance]

[https://hawkesbaylabmanual.co.nz/wiki/images/a/af/HCUE_Troubleshooting.pdf Hemocue Troubleshooting]

[https://hawkesbaylabmanual.co.nz/wiki/images/2/28/HCUE_Competency_Assessment.pdf Hemocue Competency Assessment]

File:Hemocue Quality Control.pdf

2024-10-03T00:40:19Z

Rwarwick:

Tests:Hemocue

2024-10-02T23:06:22Z

Rwarwick:

{{DISPLAYTITLE: Hemocue}}
[[Category:Tests]]
[[Category:POCT]]
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of Care, Hemocue, Hb, Hemoglobin
|-
|'''Specimen'''
|Finger-prick capillary blood
|-
|'''Test Availability'''
|24/7
|-
|'''Where analysed'''
|Hastings Theatre
|-
|'''Department'''
|Point of Care ext. 2453
|}
[https://hawkesbaylabmanual.co.nz/wiki/images/3/3f/HCUE_Overview.pdf Hemocue Hb 201+ Overview]

[https://hawkesbaylabmanual.co.nz/wiki/images/a/ac/Hemocue_Patient_Testing.pdf Hemocue Patient Testing]

[https://hawkesbaylabmanual.co.nz/wiki/images/1/18/HCUE_Patient_testing_quick_guide.pdf Hemocue Patient Testing Quick Guide]

[https://hawkesbaylabmanual.co.nz/wiki/images/f/f6/HCUE_Maintenance.pdf Hemocue Maintenance]

[https://hawkesbaylabmanual.co.nz/wiki/images/a/af/HCUE_Troubleshooting.pdf Hemocue Troubleshooting]

[https://hawkesbaylabmanual.co.nz/wiki/images/2/28/HCUE_Competency_Assessment.pdf Hemocue Competency Assessment]

File:Hemocue Patient Testing.pdf

2024-10-02T23:05:04Z

Rwarwick:

File:HCUE Overview.pdf

2024-10-02T22:54:47Z

Rwarwick: Rwarwick uploaded a new version of File:HCUE Overview.pdf

Tests:POCT Glucose/Ketone Nova Meter

2024-09-17T02:26:27Z

Rwarwick:

{{DISPLAYTITLE: POCT Glucose/Ketone/Lactate Nova Meter}}
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of Care, Glucose, Ketone, Lactate, Nova, Statstrip
|-
|'''Specimen'''
|Finger-prick, capillary blood
|-
|'''Paediatric Specimen'''
|Finger-prick, capillary blood
|-
|'''Test Availability'''
|24/7 - meters on each ward
No after-hours support from the laboratory
|-
|'''Where analysed'''
|Hastings, Wairoa and CHB wards
|-
|'''Department'''
|Point of Care Testing ext. 2453
|}

[https://hawkesbaylabmanual.co.nz/wiki/images/0/0c/Nova_Meters_-_Glucose-Ketone.pdf Nova Meter - Glucose/Ketone Overview]

[https://hawkesbaylabmanual.co.nz/wiki/images/f/f4/Nova_Meter_Lactate.pdf Nova Meter - Lactate]

[https://hawkesbaylabmanual.co.nz/wiki/images/0/03/Nova_Meters_Quality_Control.pdf Nova Meter - Quality Control]

[https://hawkesbaylabmanual.co.nz/wiki/images/c/ce/Nova_Meter_Troubleshooting.pdf Nova Meter - Troubleshooting]

[[Media:Nova Meter - New User - Nurses.pdf|Nova Meter - Competency Assessment Glucose/Ketone - Nurses]]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e6/Nova_Meter_Wairoa_and_Maternity_Competency.pdf Nova Meter - Competency Assessment - Wairoa and Maternity]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e6/Nova_Meter_Wairoa_and_Maternity_Competency.pdf Nova Meter - Competency Assessment - Health Care Associate]
[[Category:Tests]]
[[Category:POCT]]

Tests:POCT Glucose/Ketone Nova Meter

2024-09-17T02:25:31Z

Rwarwick:

{{DISPLAYTITLE: Glucose/Ketone/Lactate Nova Meter}}
{| class="wikitable"
|'''Synonym(s)'''
|POCT, Point of Care, Glucose, Ketone, Lactate, Nova, Statstrip
|-
|'''Specimen'''
|Finger-prick, capillary blood
|-
|'''Paediatric Specimen'''
|Finger-prick, capillary blood
|-
|'''Test Availability'''
|24/7 - meters on each ward
No after-hours support from the laboratory
|-
|'''Where analysed'''
|Hastings, Wairoa and CHB wards
|-
|'''Department'''
|Point of Care Testing ext. 2453
|}

[https://hawkesbaylabmanual.co.nz/wiki/images/0/0c/Nova_Meters_-_Glucose-Ketone.pdf Nova Meter - Glucose/Ketone Overview]

[https://hawkesbaylabmanual.co.nz/wiki/images/f/f4/Nova_Meter_Lactate.pdf Nova Meter - Lactate]

[https://hawkesbaylabmanual.co.nz/wiki/images/0/03/Nova_Meters_Quality_Control.pdf Nova Meter - Quality Control]

[https://hawkesbaylabmanual.co.nz/wiki/images/c/ce/Nova_Meter_Troubleshooting.pdf Nova Meter - Troubleshooting]

[[Media:Nova Meter - New User - Nurses.pdf|Nova Meter - Competency Assessment Glucose/Ketone - Nurses]]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e6/Nova_Meter_Wairoa_and_Maternity_Competency.pdf Nova Meter - Competency Assessment - Wairoa and Maternity]

[https://hawkesbaylabmanual.co.nz/wiki/images/e/e6/Nova_Meter_Wairoa_and_Maternity_Competency.pdf Nova Meter - Competency Assessment - Health Care Associate]
[[Category:Tests]]
[[Category:POCT]]

File:ABL90 POCT Blood Gas Analyser QC and Calibrations.pdf

2024-09-17T02:24:55Z

Rwarwick: Rwarwick uploaded a new version of File:ABL90 POCT Blood Gas Analyser QC and Calibrations.pdf

File:Clinitek Urinalysis Quality Control.pdf

2024-09-17T02:23:59Z

Rwarwick: Rwarwick uploaded a new version of File:Clinitek Urinalysis Quality Control.pdf

File:Hba1c Patient testing quick guide.pdf

2024-08-29T03:28:40Z

Rwarwick: Rwarwick uploaded a new version of File:Hba1c Patient testing quick guide.pdf